NCT06856226View on ClinicalTrials.gov

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2028

Conditions

LeukemiaLymphomaHematologic Malignancy

Interventions

OTHER

Arm 1

Short tandem repeat (STR) analysis from genomic DNA extracted from biospecimens.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT06856226 - Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant | Biotech Hunter | Biotech Hunter